Cisplatin-based Chemotherapy

Treatment for Hepatoblastoma

Typical Dosage: Various regimens, e.g., Cisplatin 80-100 mg/m2 per cycle

Effectiveness

85%

Safety Score

25%

Clinical Trials

Participants

15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️

Meth💀

Cigarettes🚬

Chemo☢️

Alcohol🍺

Morphine💊

Antibiotics💉

Tylenol💊

Exercise🏃

Water💧

DangerousModerateSafe

Treatment Details

Dosage Range

Various regimens, e.g., Cisplatin 80-100 mg/m2 per cycle

Time to Effect

2-4 weeks

Treatment Duration

4-6 months

Evidence Quality

HIGH

Confidence Score

90%confidence in effectiveness data

Health Economics

Annual Cost of Care

Drug Cost:$5,000

Monitoring:$40,000

Side Effect Mgmt:$50,000

Total Annual:$95,000

Cost-Effectiveness Analysis

Cost-Effectiveness Rating

GOOD

QALYs Gained

Outcome-Based Costs

Cost per Responder

$135,714.28

Cost per Remission

$135,714.28

Cisplatin-based Chemotherapy Outcomes

for Hepatoblastoma

Efficacy Outcomes

Overall Effectiveness

+85%

Response Rate

+70%

Remission Rate

+70%

Common Side Effects

Nausea and vomiting

+85%

Myelosuppression

+80%

Ototoxicity

+40%

Nephrotoxicity

+35%

Fatigue

+80%

Sources:

droracle.ai

nih.gov

researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials

No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials

1 completed trial for Cisplatin-based Chemotherapy in Hepatoblastoma

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

NCT00980460COMPLETEDPHASE3

View Study

236 participants

INTERVENTIONAL

Birmingham, United States +208 more

Started: Sep 15, 2009